LCMV gp33–41 - 1 mg
- Cat.Number : AS-61296
 - Manufacturer Ref. :
 - 
                                Availability : 
        In stock
 
Alternative choices
This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41.
Specifications
| Chemistry | |
| Sequence one letter code | 
                                    
  | 
                        
|---|---|
| Sequence three letter code | 
                                    
  | 
                        
| Molecular Formula | 
                                    
  | 
                        
| Molecular Mass/ Weight | 
                                    
  | 
                        
| Modification | |
| Conjugation | 
                                    
  | 
                        
| Quantity & Purity | |
| Purity | 
                                    
  | 
                        
| Storage & stability | |
| Form | 
                                    
  | 
                        
| Storage Conditions | 
                                    
  | 
                        
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage | 
                                    
  | 
                        
| Source | |
| Source / Species | 
                                    
  | 
                        
You may also be interested in the following product(s)
            
            
            References
A Naturally Processed Mitochondrial Self-Peptide in Complex with Thymic Mhc Molecules Functions as a Selecting Ligand for a Viral-Specific T Cell Receptor
J Exp Med . 2001 Sep 24 ; 194(7) 883 | DOI : https://doi.org/10.1084/jem.194.7.883
- T. Sasada
 - et al
 
In Vivo Generation of Cytotoxic T Cells from Epitopes Displayed on Peptide-Based Delivery Vehicles
J Immunol . 2002 Jun 01 ; 168(11) 5709 | DOI : https://doi.org/10.4049/jimmunol.168.11.5709
- K. Kawamura
 - et al
 
Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells
Cancer Immunity . 2005 Jan 01 ; 5(1) 8 | DOI : 15934727
- M. Spiotto
 - H. Schreiber